Angle reports wider loss, awaits FDA decision on cancer test equipment
Angle reports wider loss, awaits FDA decision on cancer test equipment
Read moreTue, 11th Feb 2020 07:41
Angle reports wider loss, awaits FDA decision on cancer test equipment
Read moreIN BRIEF: Angle enrolls 200 patients for ovarian cancer test study
Read more(Sharecast News) - Liquid biopsy company Angle announced on Monday that its 200-patient ovarian cancer clinical verification study had completed patient enrolment.
Read moreUK earnings, trading statements calendar - next 7 days
Read more(Sharecast News) - Liquid biopsy company Angle has secured its first large-scale pharma services contract, it announced on Friday.
Read moreTRADING UPDATES: AFC raises GBP36 million; Angle wins service contract
Read moreIN BRIEF: Angle launches clinical services laboratories in UK and US
Read more(Sharecast News) - Liquid biopsy company Angle has completed the fitout and staffing of its clinical services laboratories in Guildford and Pennsylvania, it announced on Tuesday.
Read moreTRADING UPDATES: Futura signs development deal; UKOG gets day in court
Read moreAIM WINNERS & LOSERS: Futura Medical rises on financing transaction
Read moreAngle Shares Jump On Recent Parsortix System Research Results
Read moreIN BRIEF: Angle Says Athens University Study Shows Value Of Parsortix
Read moreTRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash
Read moreAngle Reports Parsortix System Can Isolate Circulating Tumour Cells
Read moreLONDON AIM WINNERS & LOSERS: Sabien Sinks On Ptarmigan Deal Withdrawal
Read more